Summary
In order to accelerate the development of the nanomedicine business in Europe, EUNCL interconnected 8 European and 1 American key reference facilities with a proven expertise in physical, chemical, in vitro and in vivo biological characterisation of nanoparticles for medical...
More information & hyperlinks
| Web resources: | http://www.eu-ncl.eu |